论文部分内容阅读
肝硬化是一种常见的慢性进行性肝脏疾病,病理特征为广泛肝细胞坏死、残存肝细胞结节样增生、结缔组织增生与纤维隔形成,继而失代偿期引发肝脏功能损害和门脉高压症等临床表现,与此可伴发不同程度的胆道系统病变,主要表现为胆结石及非特异性炎症。临床研究证实较非肝硬化患者而言,肝硬化患者胆结石发病率升高2~3倍~([1])。与非肝硬化患者不同,肝硬
Cirrhosis is a common chronic progressive liver disease characterized by extensive hepatic necrosis, residual hepatocyte nodular hyperplasia, connective tissue hyperplasia and septa formation followed by decompensation of hepatic dysfunction and portal hypertension Disease and other clinical manifestations, which may be associated with varying degrees of biliary system lesions, mainly as gallstones and non-specific inflammation. Clinical studies have shown that the incidence of gallstone in cirrhotic patients is 2-3 times higher than in non-cirrhotic patients. [1] Unlike non-cirrhotic patients, liver cirrhosis